- Login
- Manage Portfolio
- Post a StockTalk
- Write an Instablog
- Get Daily Email Alert
-
Seeking Alpha
-
Friday, November 27th
The EHR Effect: 8 Health Stocks Set to Benefit in 2010
-
Thursday, November 26th
Boston Scientific Gets Clearance for Esophageal Stent
-
Sanofi Expands Regeneron Agreement
-
FDA Approves Gen-Probe Assay
-
Theravance, Inc.: Wait to Buy on Dip
-
Insider Buying Bodes Well For Orexigen
-
CytRx Announces First of Two Positive Developments Ahead
-
SIGA Shares Could Double on Pending Government News
-
Financing Drug Discovery: Recent Deals
-
Novartis Partners with U.S. Government for Faster Flu Vaccine Manufacturing
-
Merck Triumphs in Defense of Osteoporosis Drug...for Now
-
Bristol-Myers Squibb Sees Perfect Timing to Divest Huge Mead Johnson Nutrition Stake
-
Wednesday, November 25th
Human Genome Sciences Begins Tumor Treatment Trial
-
Novartis Deal Gives Incyte a Boost
-
Medtronic Beats Second Quarter Estimates
-
Genzyme's Renagel / Renvela Franchise: Investors Would Be Wise to Reevaluate
-
Merck Serono to Spend $225 Million on New Beijing R&D Center
-
Under the Radar Healthcare Stocks: Protox, Pressure BioSciences, Unilife
-
Watson Pharmaceutical Financial Gauge Analysis for the September 2009 Quarter
-
St. Jude Medical: Filling-the-Gap on Short Squeeze
-
Tuesday, November 24th
Still Believe in Antigenics
-
Is America Ready for Assembly Line Medicine?
-
BioMed News Bytes: Transcept, ProUroCare, SciClone, ABIO
-
CytRx Corporation: Key Developments Ahead
-
Abbott Acquires Global Rights to Chronic Pain Treatment